Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (1376)	11/4/1999 7:53:00 AM
From: Dan P	Read Replies (1) \| Respond to of 5582

SW: According to your numbers, Gumm could net $17 million or more based on $1.75 per bottle profit. At around 7.5 million shares, net earnings of approximately $2.50. Those are some staggering potential earnings, if they come through. Obviously, success will depend on the results from the additional studies. International distribution will smooth out the curve over the 12 month period, since of course colds are mostly a winter phenomenon in the US. Cheers Dan